Literature DB >> 34903568

Effect of Nudge-Based Intervention on Adherence to Physician Visit Recommendations and Early Health Outcomes among Individuals Identified with Chronic Kidney Disease in Screens.

Shingo Fukuma1, Shusaku Sasaki2, Masataka Taguri3, Rei Goto4, Toshihiro Misumi5, Yusuke Saigusa5, Yusuke Tsugawa6,7.   

Abstract

BACKGROUND: Although CKD screening programs have been provided in many settings, little is known as to how we can effectively translate those screening programs into improved health.
METHODS: We conducted a randomized clinical trial on national health screening for CKD in Japan between April 2018 and March 2019. A total of 4011 participants in CKD screening programs aged 40-63 years were randomly assigned to two interventions or the control, with a ratio of 2:2:1, respectively: (1) the nudge-based letter that contained a message on the basis of behavioral economics, (2) the clinical letter including general information about CKD risks, and (3) the control (informed only of the screening results). The main outcome was adherence to a recommended physician visit within 6 months of the intervention. The secondary outcomes were eGFR, proteinuria, and BP 1 year after the intervention.
RESULTS: Compared with the control group, the probability of undergoing a recommended physician visit was higher among participants who received the nudge-based letter (19.7% for the intervention group versus 15.8% for the control; difference, +3.9 percentage points [pp]; 95% CI, +0.8 to +7.0; P=0.02) and the clinical letter (19.7% versus 15.8%; difference, +3.9 pp; 95% CI, +0.8 to +7.0; P=0.02). We found no evidence that interventions were associated with improved early health outcomes.
CONCLUSIONS: The behavioral economics intervention tested in this large RCT had limited effect on changing behavior or improving health outcomes. Although the approach has promise, this study demonstrates the challenge of developing behavioral interventions that improve the effectiveness of CKD screening programs.Clinical Trial registry name and registration number: University Hospital Medical Information Network Clinical Trial Registry, UMIN000035230.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  behavioral economic intervention; behavioral economics; chronic kidney disease; health care; outcome assessment; randomized clinical trial

Mesh:

Year:  2021        PMID: 34903568      PMCID: PMC8763194          DOI: 10.1681/ASN.2021050664

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  24 in total

1.  Estimating standardized parameters from generalized linear models.

Authors:  S Greenland
Journal:  Stat Med       Date:  1991-07       Impact factor: 2.373

2.  The CKD-EPI equation and MDRD study equation find similar prevalence of chronic kidney disease in Asian populations.

Authors:  Charumathi Sabanayagam; Tien Y Wong; E Shyong Tai
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

3.  Prevalence of chronic kidney disease in China: a cross-sectional survey.

Authors:  Luxia Zhang; Fang Wang; Li Wang; Wenke Wang; Bicheng Liu; Jian Liu; Menghua Chen; Qiang He; Yunhua Liao; Xueqing Yu; Nan Chen; Jian-e Zhang; Zhao Hu; Fuyou Liu; Daqing Hong; Lijie Ma; Hong Liu; Xiaoling Zhou; Jianghua Chen; Ling Pan; Wei Chen; Weiming Wang; Xiaomei Li; Haiyan Wang
Journal:  Lancet       Date:  2012-03-03       Impact factor: 79.321

4.  Undiagnosed and untreated chronic kidney disease and its impact on renal outcomes in the Japanese middle-aged general population.

Authors:  Yukari Yamada; Tatsuyoshi Ikenoue; Yoshiyuki Saito; Shingo Fukuma
Journal:  J Epidemiol Community Health       Date:  2019-09-28       Impact factor: 3.710

5.  Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial.

Authors:  Daniella Meeker; Jeffrey A Linder; Craig R Fox; Mark W Friedberg; Stephen D Persell; Noah J Goldstein; Tara K Knight; Joel W Hay; Jason N Doctor
Journal:  JAMA       Date:  2016-02-09       Impact factor: 56.272

6.  Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.

Authors:  Cornelis Boersma; Ron T Gansevoort; Petros Pechlivanoglou; Sipke T Visser; Flip F J van Toly; Lolkje T W de Jong-van den Berg; Paul E de Jong; Maarten J Postma
Journal:  Clin Ther       Date:  2010-06       Impact factor: 3.393

7.  Associations between access to care and awareness of CKD.

Authors:  Anuja Shah; Linda F Fried; Shu-Cheng Chen; Yang Qiu; Suying Li; Kerri L Cavanaugh; Keith C Norris; Adam T Whaley-Connell; Peter A McCullough; Rajnish Mehrotra
Journal:  Am J Kidney Dis       Date:  2012-03       Impact factor: 8.860

8.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

9.  Mass screening for chronic kidney disease in rural and remote Canadian first nations people: methodology and demographic characteristics.

Authors:  Barry Lavallee; Caroline Chartrand; Lorraine McLeod; Claudio Rigatto; Navdeep Tangri; Allison Dart; Audrey Gordon; Stephanee Ophey; Paul Komenda
Journal:  Can J Kidney Health Dis       Date:  2015-03-19

10.  Nudging patients with chronic kidney disease at screening to visit physicians: A protocol of a pragmatic randomized controlled trial.

Authors:  Shingo Fukuma; Tatsuyoshi Ikenoue; Shusaku Sasaki; Yusuke Saigusa; Toshihiro Misumi; Yoshiyuki Saito; Yukari Yamada; Rei Goto; Masataka Taguri
Journal:  Contemp Clin Trials Commun       Date:  2019-08-16
View more
  1 in total

1.  Nudging Behavioral Economics into Nephrology Care Delivery Research.

Authors:  Adam S Wilk; Delphine S Tuot
Journal:  J Am Soc Nephrol       Date:  2022-01       Impact factor: 14.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.